Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2013 - 2026)

Amphastar Pharmaceuticals' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.87 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 62.01% year-over-year to 1.87 in Q1 2026; TTM through Mar 2026 was 4.78, a 53.37% decrease from a year earlier, with the FY2025 full-year figure at 0.34, down 84.04% from the prior year.
• Interest Coverage Ratio eased to 1.87 in Q1 2026 per AMPH's latest filing, from 5.37 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 36.02 in Q1 2022 and bottomed at 418.45 in Q4 2023.
• The 5-year median for Interest Coverage Ratio is 1.87 (2026), against an average of 17.43.
• Across the five-year window, Interest Coverage Ratio tumbled 2032.31% in 2023 and soared 500.49% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 21.66 in 2022, then tumbled by 2032.31% to 418.45 in 2023, then jumped by 103.73% to 15.6 in 2024, then plunged by 65.58% to 5.37 in 2025, then sank by 65.21% to 1.87 in 2026.
• Per Business Quant, the three latest AMPH Interest Coverage Ratio figures stand at 1.87 (Q1 2026), 5.37 (Q4 2025), and 0.76 (Q3 2025).